What does CUSIP 007002108 represent in this 13F holders report?

CUSIP 007002108 is the security identifier for ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 used to aggregate holder disclosures.

How many institutions held ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 in Q2 2021?

60 institutional investors reported ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 for Q2 2021. Use the holders table for investor-level position and value details.

Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET)

CUSIP: 007002108

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class: Equity / Common Stock, par value $0.0001
Shares outstanding: 9,599,852
Total 13F shares: 21,191,598
Share change: +844,475
Total reported value: $218,012,000
Price per share: $10.29
Number of holders: 60
Value change: +$7,951,899
Number of buys: 38
Number of sells: 22

Quarterly Holders Quick Answers

What is CUSIP 007002108?
CUSIP 007002108 identifies ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2021
Previous quarter: Q1 2021

Recent filing periods for CUSIP 007002108:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ORBIMED ADVISORS LLC	13F	Company	75%	7,232,856	$94,606,000	—	31 Mar 2021	13F
Avidity Partners Management LP	13F	Company	23%	2,230,000	$29,168,000	—	31 Mar 2021	13F
Abingworth LLP	13F	Company	17%	1,615,385	$20,968,000	—	31 Mar 2021	13F
Consonance Capital Management LP	13F	Company	13%	1,216,860	$15,917,000	—	31 Mar 2021	13F
Point72 Asset Management, L.P.	13F	Company	11%	1,048,100	$13,709,000	—	31 Mar 2021	13F
VR Adviser, LLC	13F	Company	10%	1,000,000	$13,080,000	—	31 Mar 2021	13F
VANGUARD GROUP INC	13F	Company	8.4%	807,988	$10,569,000	—	31 Mar 2021	13F
Johnson & Johnson Innovation - JJDC, Inc.	13F	Company	7.6%	728,944	$9,535,000	—	31 Mar 2021	13F
BlackRock Finance, Inc.	13F	Company	5.1%	489,628	$6,404,000	—	31 Mar 2021	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	5.1%	488,000	$6,383,000	—	31 Mar 2021	13F
Ally Bridge Group (NY) LLC	13F	Company	4.4%	425,000	$5,559,000	—	31 Mar 2021	13F
Nantahala Capital Management, LLC	13F	Company	4.1%	395,875	$5,178,000	—	31 Mar 2021	13F
DAFNA Capital Management LLC	13F	Company	4%	385,077	$5,037,000	—	31 Mar 2021	13F
Laurion Capital Management LP	13F	Company	3.6%	341,269	$4,464,000	—	31 Mar 2021	13F
Granite Point Capital Management, L.P.	13F	Company	2.5%	240,000	$3,139,000	—	31 Mar 2021	13F
BAILLIE GIFFORD & CO	13F	Company	1.9%	181,626	$2,375,000	—	31 Mar 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	1.9%	180,041	$2,355,000	—	31 Mar 2021	13F
Altium Capital Management LLC	13F	Company	1.5%	142,289	$1,861,000	—	31 Mar 2021	13F
Ikarian Capital, LLC	13F	Company	1.4%	135,094	$1,768,000	—	31 Mar 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.2%	119,315	$1,560,000	—	31 Mar 2021	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	1.1%	102,444	$1,340,000	—	31 Mar 2021	13F
KINGDON CAPITAL MANAGEMENT, L.L.C.	13F	Company	1%	100,000	$1,308,000	—	31 Mar 2021	13F
J. Goldman & Co LP	13F	Company	1%	96,046	$1,256,000	—	31 Mar 2021	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.9%	86,292	$1,129,000	—	31 Mar 2021	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.8%	76,381	$999,000	—	31 Mar 2021	13F
ExodusPoint Capital Management, LP	13F	Company	0.75%	71,687	$938,000	—	31 Mar 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.48%	45,755	$598,000	—	31 Mar 2021	13F
Bank of New York Mellon Corp	13F	Company	0.45%	42,803	$560,000	—	31 Mar 2021	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.43%	41,421	$542,000	—	31 Mar 2021	13F
Maven Securities LTD	13F	Company	0.39%	36,989	$489,000	—	31 Mar 2021	13F
D. E. Shaw & Co., Inc.	13F	Company	0.34%	32,486	$425,000	—	31 Mar 2021	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.29%	27,497	$360,000	—	31 Mar 2021	13F
CITADEL ADVISORS LLC	13F	Company	0.3%	28,422	$355,000	—	31 Mar 2021	13F
NORTHERN TRUST CORP	13F	Company	0.27%	25,983	$340,000	—	31 Mar 2021	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.25%	24,284	$318,000	—	31 Mar 2021	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.21%	20,100	$263,000	—	31 Mar 2021	13F
JANE STREET GROUP, LLC	13F	Company	0.19%	18,200	$238,000	—	31 Mar 2021	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.44%	42,239	$230,000	—	31 Mar 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.16%	15,005	$196,000	—	31 Mar 2021	13F
Qube Research & Technologies Ltd	13F	Company	0.14%	13,567	$177,000	—	31 Mar 2021	13F
Golden State Equity Partners	13F	Company	0.14%	13,145	$172,000	—	31 Mar 2021	13F
CITIGROUP INC	13F	Company	0.12%	11,688	$153,000	—	31 Mar 2021	13F
STATE STREET CORP	13F	Company	0.11%	10,510	$137,000	—	31 Mar 2021	13F
Tower Research Capital LLC (TRC)	13F	Company	0.03%	2,477	$32,000	—	31 Mar 2021	13F
UBS Group AG	13F	Company	0.02%	1,693	$22,000	—	31 Mar 2021	13F
BANK OF MONTREAL /CAN/	13F	Company	0.01%	914	$12,000	—	31 Mar 2021	13F
ROYAL BANK OF CANADA	13F	Company	0.01%	784	$11,000	—	31 Mar 2021	13F
Penserra Capital Management LLC	13F	Company	0.01%	680	$8,000	—	31 Mar 2021	13F
MORGAN STANLEY	13F	Company	0%	476	$6,000	—	31 Mar 2021	13F
FIFTH THIRD BANCORP	13F	Company	0%	142	$2,000	—	31 Mar 2021	13F

Institutional Holders of Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) as of Q2 2021

As of 30 Jun 2021, Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) was held by 60 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,191,598 shares. The largest 10 holders included ORBIMED ADVISORS LLC, Avidity Partners Management LP, Abingworth LLP, BlackRock Inc., Point72 Asset Management, L.P., VANGUARD GROUP INC, Consonance Capital Management LP, Johnson & Johnson Innovation - JJDC, Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., and Ally Bridge Group (NY) LLC. This page lists 60 institutional shareholders reporting positions in this security for the Q2 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders

Q2 2021 holders

Holder diff

Investor	Q1 2021 Shares	Q2 2021 Shares	Share Diff	Share Chg %	Q1 2021 Value $	Q2 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.